The Japan Times - Who should get paid for nature's sequenced genes?

EUR -
AED 4.282286
AFN 72.889506
ALL 95.207603
AMD 430.01375
ANG 2.087753
AOA 1070.42764
ARS 1622.784305
AUD 1.615801
AWG 2.101792
AZN 1.980037
BAM 1.948086
BBD 2.348989
BDT 143.162498
BGN 1.947198
BHD 0.439945
BIF 3468.977203
BMD 1.166043
BND 1.484988
BOB 8.058985
BRL 5.837324
BSD 1.166277
BTN 111.748109
BWP 16.426743
BYN 3.258314
BYR 22854.438042
BZD 2.345552
CAD 1.600621
CDF 2617.765364
CHF 0.914545
CLF 0.02651
CLP 1043.367038
CNY 7.911775
CNH 7.916136
COP 4418.987218
CRC 529.980953
CUC 1.166043
CUP 30.900133
CVE 110.420738
CZK 24.310883
DJF 207.229054
DKK 7.473652
DOP 69.611585
DZD 154.439062
EGP 61.655687
ERN 17.490641
ETB 183.593618
FJD 2.556084
FKP 0.862511
GBP 0.870795
GEL 3.124803
GGP 0.862511
GHS 13.304314
GIP 0.862511
GMD 84.53284
GNF 10237.855419
GTQ 8.897767
GYD 243.990718
HKD 9.133322
HNL 31.040319
HRK 7.5352
HTG 152.719375
HUF 357.85873
IDR 20501.247154
ILS 3.384559
IMP 0.862511
INR 111.602244
IQD 1527.516012
IRR 1533346.225611
ISK 143.609809
JEP 0.862511
JMD 184.399822
JOD 0.82669
JPY 184.674396
KES 150.710561
KGS 101.97073
KHR 4678.163038
KMF 492.06927
KPW 1049.40427
KRW 1743.787798
KWD 0.359712
KYD 0.971947
KZT 552.061604
LAK 25600.468408
LBP 105018.290233
LKR 379.337915
LRD 213.677252
LSL 19.227736
LTL 3.443021
LVL 0.705327
LYD 7.380747
MAD 10.737796
MDL 20.047359
MGA 4871.140463
MKD 61.623214
MMK 2448.532445
MNT 4174.584911
MOP 9.409221
MRU 46.630148
MUR 54.687743
MVR 17.953612
MWK 2030.079949
MXN 20.097411
MYR 4.5843
MZN 74.521703
NAD 19.22769
NGN 1596.510503
NIO 42.811215
NOK 10.814812
NPR 178.792592
NZD 1.975224
OMR 0.448341
PAB 1.166257
PEN 4.019331
PGK 5.084821
PHP 71.905202
PKR 324.858355
PLN 4.243469
PYG 7106.858587
QAR 4.250809
RON 5.201602
RSD 117.404153
RUB 85.416661
RWF 1703.588468
SAR 4.323481
SBD 9.347158
SCR 15.925798
SDG 700.210747
SEK 10.964079
SGD 1.488553
SHP 0.870569
SLE 28.742478
SLL 24451.336053
SOS 666.396592
SRD 43.384983
STD 24134.730844
STN 24.778409
SVC 10.204331
SYP 128.881228
SZL 19.227966
THB 37.837714
TJS 10.898504
TMT 4.08115
TND 3.367544
TOP 2.807551
TRY 53.109051
TTD 7.918441
TWD 36.822696
TZS 3025.881057
UAH 51.26883
UGX 4361.616853
USD 1.166043
UYU 46.444895
UZS 14044.985317
VES 594.855331
VND 30719.39644
VUV 137.683599
WST 3.158251
XAF 653.355863
XAG 0.013988
XAU 0.000251
XCD 3.151288
XCG 2.101868
XDR 0.810364
XOF 650.065331
XPF 119.331742
YER 278.276306
ZAR 19.248742
ZMK 10495.787518
ZMW 21.954032
ZWL 375.465292
  • RBGPF

    -0.2100

    60.79

    -0.35%

  • RYCEF

    -0.0700

    15.93

    -0.44%

  • VOD

    -0.0300

    15.48

    -0.19%

  • CMSC

    0.0898

    23.14

    +0.39%

  • BP

    -0.0200

    44.12

    -0.05%

  • GSK

    -0.0300

    50.96

    -0.06%

  • RIO

    -2.4500

    109.59

    -2.24%

  • AZN

    -2.7600

    184.96

    -1.49%

  • BTI

    1.3500

    66.7

    +2.02%

  • NGG

    0.4500

    87.43

    +0.51%

  • BCC

    2.4200

    69.4

    +3.49%

  • RELX

    -0.1600

    31.46

    -0.51%

  • CMSD

    0.0400

    23.6

    +0.17%

  • JRI

    0.0100

    13.14

    +0.08%

  • BCE

    -0.2000

    24.19

    -0.83%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

K.Abe--JT